Dimethylamine → HCID 178489404、化合物

HRID 1865701ノート

反応式

HRID 1865701 の反応式
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]3[C:14](=C[CH:16]=2)[N:13](COC(=O)C(C)(C)C)[N:12]=[C:11]3[C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=2[O:31][CH3:32])=[CH:4][C:3]=1[C:33](=[O:37])[N:34]([CH3:36])[CH3:35].[C:38](Cl)(Cl)=[O:39].[CH3:42][N:43]([CH3:45])C.C[NH:47]C>ClCCl>[CH3:42][N:43]([CH3:45])[C:38](=[O:39])[NH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]3[C:11]([C:25]4[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=4[O:31][CH3:32])=[N:12][NH:13][C:14]3=[N:47][CH:16]=2)=[CH:4][C:3]=1[C:33]([N:34]([CH3:35])[CH3:36])=[O:37]

参加物

6

反応物 4

HCID 674DimethylamineHCID 1146TrimethylamineHCID 6371PhosgeneHCID 68662452HCID 68662452、化合物

生成物 1

HCID 178489404HCID 178489404、化合物収率 21%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

A solution of 2,2-dimethyl-propionic acid 5-(4-amino-3-dimethylcarbamoyl-phenyl)-3-(2-methoxy-phenyl)-indazol-1-ylmethyl ester (0.5 g, 1 mmol) in dichloromethane (10 ml) was stirred at 0° C. for 15 minutes. Then phosgene (673 μl, 1.2 mmol; 20% in toluene) was added and after 1 minute trimethylamine (201 μl, 1.4 mmol), followed by dimethylamine (722 pt, 1.4 mmol; 2 M in THF). The mixture was allowed to stir until the ice melted and then at room temperature for another hour. The crude was worked up by removing solvent and purified on silica chromatography. The resulting product was dissolved in ethanol (6 ml) and 2 M aqueous NaOH (2 ml). The mixture was stirred at room temperature for 4 hours or until no more starting material remained. The solvent was removed under reduced pressure. The crude was neutralized with 1 N HCl and purified on reverse phase HPLC to afford 2-(3,3-dimethyl-ureido)-5-[3-(2-methoxy-phenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N,N-dimethyl-benzamide (94 mg, 21% yield). 1H NMR (500 MHz, DMSO-d6) δ 2.91 (s, 6H), 3.01 (s, 6H), 3.84 (s, 3H), 7.09 (m, 1H), 7.22 (d, 1H), 7.46 (m, 1H), 7.65 (d, 1H), 7.69 (s, 1H), 7.77 (d, 1H), 7.96 (d, 1H), 8.32 (s, 1H), 8.64 (s, 1H), 8.85 (s, 1H), 13.80 (s, 1H). MS: m/z 459.2 (M+H+).

後処理

  1. waitat room temperature for another hour
  2. customby removing solvent
  3. custompurified on silica chromatography
  4. dissolutionThe resulting product was dissolved in ethanol (6 ml)
  5. customThe solvent was removed under reduced pressure
  6. custompurified on reverse phase HPLC

出典と根拠

ORDレコード
ord-ec08abe1643441028f9c39a3e99877b9
出典データセット
uspto-grants-2009_12
特許番号
US07626021B2

反応ノート

読み込み中…